Patents by Inventor Derek Anthony Demaine

Derek Anthony Demaine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7288564
    Abstract: Compounds of formula (I) or salts or solvates thereof or physiologically functional derivatives thereof are potent binders at the EP4 receptor and are of use in the treatment or prevention of conditions such as a pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.
    Type: Grant
    Filed: December 20, 2001
    Date of Patent: October 30, 2007
    Assignee: Glaxo Group Limited
    Inventors: Derek Anthony Demaine, Gerard Martin Paul Giblin, Rachel Elizabeth Hosking, Graham George Adam Inglis, Xiao Qing Lewell, Simon John Fawcett MacDonald, Andrew McMurtrie Mason, Martin Edward Swarbrick
  • Patent number: 7230114
    Abstract: Compounds of formula (I), methods for their preparation and their use in the manufacture of neuraminidase inhibitor conjugates.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: June 12, 2007
    Assignee: Biota Scientific Management Pty Ltd
    Inventors: Brian David Judkins, Simon John Fawcett MacDonald, Derek Anthony Demaine, Graham George Adam Inglis, Julie Nicole Hamblin
  • Publication number: 20040092569
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: December 10, 2003
    Publication date: May 13, 2004
    Inventors: Derek Anthony Demaine, Gerard Martin Paul Giblin, Rachel Elizabeth Hosking, Graham George Adam Inglis, Xiao Qing Lewell, Simon John Fawcett MacDonald, Andrew McMurtrie Mason, Martin Edward Swarbrick